Release Date: 19/07/10 18:34 Summary: Notice of becoming a substantial holder from WAM Price Sensitive: No Download Document 128.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%